Nustendi Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Blue, oval, film-coated tablet of approximately 15.00 mm × 7.00 mm × 5.00 mm debossed with "818" on one side and "ESP" on the other side.
Each film-coated tablet contains 180 mg of bempedoic acid and 10 mg of ezetimibe.
Excipient(s) with known effect: Each 180 mg/10 mg film-coated tablet contains 71.6 mg of lactose.
Excipients/Inactive Ingredients: Tablet core: Lactose monohydrate, Microcrystalline cellulose (E460), Sodium starch glycolate (Type A grade), Hydroxypropyl cellulose (E463), Magnesium stearate (E470b), Colloidal anhydrous silica (E551), Sodium laurilsulfate (E487), Povidone (K30) (E1201).
Film-coating: Partially hydrolyzed poly(vinyl alcohol) (E1203), Talc (E553b), Titanium dioxide (E171), Indigo Carmine Aluminium Lake (E132), Glycerol monocaprylocaprate, Sodium laurilsulfate (E487), Brilliant Blue FCF Aluminium Lake (E133)).

Manufacturer:

Daiichi Sankyo

Distributor:

Zuellig

Agencia Lei Va Hong